Clinical trials

9

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Community Care Intervention to Decrease COVID-19 Vaccination Inequities

The purpose of this study is to find out if a community health workers (CHW) intervention conducted in Federally Qualified Health Centers (FQHCs) can increase the number of adults with chronic illnesses who are up-to-date with their COVID-19 and influenza vaccines.

Participants needed: 800
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: RANDUpdated: May 15, 2026Locations: 4
Eligibility criteria

Not listed

Status: Recruiting

Testing ALERT With GTO in Middle Schools

To test the efficacy of Project ALERT with the support enhancement tool, Getting To Outcomes.

Participants needed: 42
Trial details
Age: 11-70Biological sex: AllType: InterventionalSponsor: RANDUpdated: May 13, 2026Locations: 1
Eligibility criteria

Eligibility for student participants: all students in 7th grade, primarily aged... [+1]

Not meeting eligibility criteria

Status: Recruiting

The Impact of Pre-emptive Home Delivery of ORS + Zinc on Treatment for Child Diarrhea

The aim of this clustered randomized controlled trial is to evaluate whether free and pre-emptive distribution of Oral Rehydration Salts (ORS) and Zinc at home increases the use of ORS to treat diarrhea cases among children under the age of 5 in Bauchi, Nigeria. The primary research questions for the study are: * RQ1a: Does pre-emptive home delivery with free distribution of ORS and zinc coupled with information about the importance of proper treatment (henceforth referred to as "the intervention") result in greater use of ORS to treat child diarrhea (for children under the age of 5) over the 6 months following the deliveries, relative to the status quo (i.e., in the absence of such an intervention)? * RQ1b: Does the intervention result in greater use of ORS to treat child diarrhea (for children under the age of 5) over the 12 months following the deliveries, relative to the status quo? * RQ1.1: How much does the effect of the intervention on use of ORS to treat child diarrhea (for children under the age of 5) change over time? All wards in Bauchi state will be randomly assigned to one of two groups: * treatment, where all households with at least one child under the age of 5 will receive free pre-emptive ORS and zinc co-packs - with two ORS sachets and 10 zinc tablets per child - coupled with information about the importance of proper treatment * delayed-start control, with care as usual during the evaluation period and intervention delivery post evaluation) groups. A total of 1,732 enumeration areas (EAs) will be sampled across all wards for the study period. Within each EA, 20 eligible households will be randomly sampled for surveys during each wave of data collection: baseline, endline wave 1 (over 1-6 months post intervention), and endline wave 2 (over 7-12 months post intervention). The primary outcomes for the study include the use of ORS to treat child diarrhea over 6 months post-intervention, over 12 months post-intervention, and over each month until 12 months post-intervention.

Participants needed: 103,920
Trial details
Age: 15+Biological sex: AllType: InterventionalSponsor: RANDUpdated: May 13, 2026Locations: 1
Eligibility criteria

At least 15 years old [+2]

Living in a temporary home (nomadic population) [+2]

Status: Recruiting

Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)

Brief motivational interviewing intervention to address alcohol use among diverse teens 12-17.

Participants needed: 500
Trial details
Age: 12-19Biological sex: AllType: InterventionalSponsor: RANDUpdated: Mar 6, 2026Locations: 2
Eligibility criteria

receive health care at one of two participating health systems [+2]

if they don't meet the inclusion criteria, they will be excluded

Status: Recruiting

Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder

The ADAPT-ED study is a two-stage, sequential multiple assignment randomized trial (SMART) to inform the development of an adaptive intervention that is optimally effective in increasing long-term buprenorphine use for adults presenting to the ED with probable opioid use disorder (OUD).

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: RANDUpdated: Feb 19, 2026Locations: 1
Eligibility criteria

Presented for ED care at ARMC [+5]

Status: Not yet recruiting

Game Changers for Family Planning Peer Advocacy Program

This study will adapt the Game Changers peer advocacy training model for family planning context and pilot test the feasibility, acceptability and preliminary efficacy of the intervention to empower female contraception users to advocate for contraception use among women in their social networks who have unmet need for contraception.

Participants needed: 192
Trial details
Phase: Phase 1, Phase 2Age: 18-49Biological sex: FemaleType: InterventionalSponsor: RANDUpdated: Dec 31, 2025
Eligibility criteria

MC user for past year [+2]

Status: Not yet recruiting

The Impact of Virtual Doula Services on Birth Outcomes in Rural Communities

This study will assess the impact of virtual doula care on birth and postnatal outcomes among rural mothers. The goal of virtual doula services is to improve access to care in underserved communities and decrease urban-rural differences in key maternal health outcomes including mode of birth (cesarean vs vaginal) and birth satisfaction. By implementing a digital randomized controlled trial, the study team will efficiently recruit a national sample of rural pregnant women to provide evidence of the effectiveness of virtual doula care, the appropriateness of virtual visits for different care and support needs, and the role of virtual care in improving maternal health.

Participants needed: 614
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: RANDUpdated: Dec 22, 2025Locations: 1
Eligibility criteria

18-45 years of age [+2]

non-singleton pregnancy [+3]

Status: Recruiting

INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)

Low medication adherence when initiating antiretroviral treatment (ART) is a key barrier to HIV virologic suppression, resulting in avoidable cases of drug resistance, death, and viral transmission. Routinized pill-taking can lead to successful long-term ART adherence, and short-term behavioral economics-based supports are a novel way to overcome the limited success of existing routinization interventions. This study proposes to test this combined approach for promoting long-term ART adherence using a Stage III Sequential, Multiple Assignment, Randomized Trial (SMART) design in one of the largest HIV clinics in Uganda to identify the most cost-effective adaptive intervention that if found effective is generalizable to other settings and other chronic diseases.

Participants needed: 550
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: RANDUpdated: Sep 11, 2025Locations: 1
Eligibility criteria

Male and female clients age 18 and older. [+5]

Not mentally fit to consent. [+2]

Status: Recruiting

Families Left Behind

The United States is facing unprecedented rates of drug overdose deaths, profoundly impacting millions of families who are left to navigate their grief. Those bereaved by overdose experience a unique form of grief characterized by feelings of guilt, shame, and blame, which can worsen their suffering and deter them from seeking help. Individuals coping with overdose loss often endure more severe health consequences compared to those grieving non-drug related deaths, including prolonged grief disorder, substance use disorders, PTSD, depression, and suicidal thoughts. Moreover, bereaved individuals, particularly those with a history of substance use, may engage in risky behaviors as a means of coping, further exacerbating the risk of overdose and mortality within this vulnerable population. Peer grief support interventions have emerged as a promising approach to assist those experiencing such losses. To combat these outcomes, we are collaborating with Peer Community Support Partners (PSCP) in a novel practice-research partnership to implement the RIVER peer grief support model. Though RIVER has shown success in community settings, it has yet to be rigorously evaluated. In a three-aim approach, this study aims to assess the effectiveness of the RIVER model while also enhancing and engaging grievers with support resources via medical examiner offices (MEOs), which routinely contact families during death investigations. This research represents a pivotal advancement in addressing the needs of the overlooked bereaved community, aligning with the NIH's Helping to End Addiction Long-term (HEAL) initiative to develop effective strategies against the opioid crisis. Together, community engagement and rigorous research efforts aim to enhance support for those affected by the tragedy of drug overdose.

Participants needed: 340
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: RANDUpdated: Aug 21, 2025Locations: 4
Eligibility criteria

people who lost a loved one to an unintentional drug overdose death within the p... [+3]

people who need hospitalization for psychiatric symptoms or substance use disord... [+3]